Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer

Norio Ohmagari1, Hend Hanna, Linda Graviss

  • 1Division of Infectious Diseases, Shizuoka Cancer Center, Shizuoka, Japan.

Cancer
|May 10, 2005
PubMed
Abstract

Insights

Multidrug-resistant Pseudomonas aeruginosa infections pose a significant threat to cancer patients. Prolonged carbapenem use and prior P. aeruginosa infection are key risk factors for these dangerous infections.

Area of Science:

  • Infectious Diseases
  • Oncology
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa causes diverse infections, with multidrug-resistant strains posing severe risks to immunocompromised cancer patients.
  • The emergence of multidrug-resistant P. aeruginosa (MDRP) in cancer patients can lead to grave outcomes.

Purpose of the Study:

  • To identify risk factors associated with multidrug-resistant P. aeruginosa infections in cancer patients.
  • To inform strategies for preventing and managing MDRP infections in this vulnerable population.

Main Methods:

  • A case-control study design was employed.
  • Cases were cancer patients with MDRP infections (polyclonal DNA patterns).
  • Controls included cancer patients with multidrug-susceptible P. aeruginosa infections and uninfected/uncolonized cancer patients with similar ICU exposure.

Main Results:

  • Significant risk factors for MDRP infection included carbapenem use for ≥7 days (P < 0.01).
  • A history of P. aeruginosa infection within the preceding year was also a significant risk factor (P < 0.01).
  • Chronic obstructive pulmonary disease (COPD) was identified as a significant risk factor (P < 0.01).

Conclusions:

  • Judicious use of carbapenems as first-line empirical therapy is recommended for cancer patients, particularly those with a history of P. aeruginosa infection or COPD.
  • Alternative antipseudomonal antibiotic regimens should be considered for high-risk cancer patients requiring hospitalization.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...